malignant hyperthermia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: All patients suspected of malignant hyperthermia episode during perioperative period
Exclusion criteria
Exclusion criteria: 1. The anesthesiologist and the patient's family members refused to use the system 2. The anesthesiologist in charge or the patient's family members signed the consent form, but the anesthesiologist or the patient's family subsequently refused to use the system and asked to withdraw from the clinical study. 3. The anesthesiologist in charge or the patient's family members signed the consent form, but the anesthesiologist or the patient's family did not use the system.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| feasibility;applicability;effectiveness; | — |
Secondary
| Measure | Time frame |
|---|---|
| survival rate;application of dantrolene; | — |
Countries
China
Contacts
West China Hospital of Sichuan University